Group 1 - The core announcement is regarding China Health Group's rights issue, where shareholders will receive 3 shares for every 10 shares held at an issue price of HKD 0.10 per share [1] - As of the record date, the company received a total of 10 valid acceptances for a total of 120 million rights shares, which represents approximately 81.1% of all rights shares available [1] - The shortfall in subscriptions amounts to 27.8 million rights shares, approximately 18.9% of the total rights shares [1] Group 2 - The unallocated rights shares will be handled according to the compensation arrangement, with Mr. Zhang and underwriters subscribing to 390,000 and 40.8 million rights shares, respectively [1] - There were no ineligible shareholders as of the record date, resulting in zero unallocated rights shares for ineligible shareholders [1] - All unallocated rights shares were successfully placed to four independent subscribers at the same price of HKD 0.10 per share, leading to no net proceeds available for distribution to non-participating shareholders [1]
中国卫生集团(00673.HK)“10供3”供股 获有效接纳81.1%